Boston Trust Walden Corp Sells 48,731 Shares of Agilent Technologies, Inc. $A

Boston Trust Walden Corp lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 17.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 229,761 shares of the medical research company’s stock after selling 48,731 shares during the period. Boston Trust Walden Corp owned about 0.08% of Agilent Technologies worth $29,490,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Capital A Wealth Management LLC raised its stake in shares of Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares during the last quarter. Ransom Advisory Ltd bought a new position in Agilent Technologies during the 1st quarter valued at approximately $32,000. Central Pacific Bank Trust Division purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $33,000. State of Wyoming bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $35,000. Finally, WFA of San Diego LLC purchased a new position in shares of Agilent Technologies during the second quarter valued at approximately $61,000.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 16,401 shares of company stock valued at $2,468,962 over the last 90 days.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on A. Barclays raised Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research note on Monday, December 15th. UBS Group lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Bank of America raised their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Finally, Robert W. Baird upped their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $161.77.

Agilent Technologies Price Performance

Shares of A opened at $137.86 on Tuesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The firm’s 50-day simple moving average is $145.20 and its two-hundred day simple moving average is $131.04. The stock has a market cap of $39.08 billion, a PE ratio of 30.17, a price-to-earnings-growth ratio of 4.02 and a beta of 1.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business’s revenue was up 9.4% on a year-over-year basis. During the same period last year, the business earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is 21.66%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.